GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Changchun BCHT Biotechnology Co (SHSE:688276) » Definitions » Additional Paid-In Capital

Changchun BCHT Biotechnology Co (SHSE:688276) Additional Paid-In Capital : ¥0 Mil(As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Changchun BCHT Biotechnology Co Additional Paid-In Capital?


Changchun BCHT Biotechnology Co's quarterly additional paid-in capital increased from Sep. 2023 (¥0 Mil) to Dec. 2023 (¥1,820 Mil) but then stayed the same from Dec. 2023 (¥1,820 Mil) to Mar. 2024 (¥0 Mil).

Changchun BCHT Biotechnology Co's annual additional paid-in capital stayed the same from Dec. 2021 (¥1,771 Mil) to Dec. 2022 (¥1,771 Mil) but then increased from Dec. 2022 (¥1,771 Mil) to Dec. 2023 (¥1,820 Mil).


Changchun BCHT Biotechnology Co Additional Paid-In Capital Historical Data

The historical data trend for Changchun BCHT Biotechnology Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Changchun BCHT Biotechnology Co Additional Paid-In Capital Chart

Changchun BCHT Biotechnology Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial 77.73 416.27 1,770.78 1,770.78 1,820.36

Changchun BCHT Biotechnology Co Quarterly Data
Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1,770.78 - 1,820.36 -

Changchun BCHT Biotechnology Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Changchun BCHT Biotechnology Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Changchun BCHT Biotechnology Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Changchun BCHT Biotechnology Co (SHSE:688276) Business Description

Traded in Other Exchanges
N/A
Address
No. 1260, Huoju Road, High-tech Development Zone, Jilin Province, Changchun, CHN, 130012
Changchun BCHT Biotechnology Co is a biopharmaceutical enterprise specializing in the research and development, production and sales of human vaccines.
Executives
Shi Nian Min Core technical personnel
Jiang Chun Lai Directors, senior managers, core technical personn
Zhu Chang Lin Core technical personnel
Wei Wei Senior management, core technical personnel
Yu Bing senior management
Liu Da Wei Senior management, core technical personnel
Meng Zhao Feng senior management
Zhang Zhe senior management
Kong Wei Directors, senior managers, core technical personn
Feng Da Qiang Supervisors

Changchun BCHT Biotechnology Co (SHSE:688276) Headlines

No Headlines